Aims: The study aimed to assess the antihyperglycemic and antidyslipidemic activities of .
Background: is an endemic plant of Morocco used in traditional medicine as an alternative treatment for diabetes.
Objective: The study was designed to examine the antihyperglycemic and antidyslipidemicability of aqueous extract of (AMAE) in experimental animal models.
Methods: The effect of the single and repeated oral administration (7 days of treatment) of AMAE (60 mg/kg) on blood glucose and lipid profile were assessed in normal and streptozotocin-induced diabetic rats. Furthermore, to confirm the antidyslipidemic effect of , a model of hyperlipidemia induced by tyloxapol (Triton WR-1339) in rats was used.
Results: The AMAE (60 mg/kg) was able to significantly reduce glycaemia, improve lipid profile and increase hepatic glycogen content in STZ-induced diabetic rats. In addition, pretreatment of rats for 7 consecutive days with an aqueous extract of (600 mg/kg) prior to tyloxapol injection prevented increases in plasma levels of total cholesterol, triglycerides and LDL-c.
Conclusion: From these observed results, it can be deduced that possesses remarkable antidiabetic and antihyperlipidemic properties.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.2174/1871529X23666230803113616 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!